Manegold et al. and Park et al. demonstrated radiosensitisation of pancreatic cancer cell lines and pancreatic tumour xenografts following treatment with a mTOR inhibitor (everolimus) and PI3K inhibitor (HS-173) respectively [50,66]. Here, MTOR is linked to familial pancreatic carcinoma.